Lifeboat Foundation

The real question is: “what is the healing time in space v. earth? What is the risk of infection on earth v. space when surgery is performed in space?” If stats show patient survival, healing, and low to no infection rates in space v. earth; we could see a time when hospital colonies in space exist to handle initially complicated and high risks surgeries by robots v. earth.

NASA is grooming its robonauts to eventually perform surgery on people living in remote areas, like space. Lisa D’Souza has more on the future droid docs.

Continue reading “NASA Teaching Robonaut to Perform Surgery” »

Although the recent article and announcement of Josiah Zayner (CA scientist) new do it yourself gene editing kit for $120 sent shock waves across industry as well as further raised the question “how do we best put controls in place to ensure ethics and prevent disaster or a crisis?”; this genie truly is out of the bottle. Because Josiah created this easily in his own kitchen, it can be replicated by many others in their own homes. What we have to decide is how to best mitigate it’s impact. Black markets & exotic animal, etc. collectors around the world will pay handsomely for this capability and raise the stakes of the most bizarre animals (deadly and non-deadly) to be created for their own profits and amusements.

BURLINGAME, Calif. — On the kitchen table of his cramped apartment, Josiah Zayner is performing the feat that is transforming biology. In tiny vials, he’s cutting, pasting and stirring genes, as simply as mixing a vodka tonic. Next, he slides his new hybrid creations, living in petri dishes, onto a refrigerator shelf next to the vegetables. And he’s packaging and selling his DIY gene-editing technique for $120 so that everyone else can do it, too.

Read more

A wearable device promises to help steady hand tremors by using an old technology—gyroscopes.

Read more

Might we one day have bionic body parts able to ward off disease and injury and even heal themselves? Today it’s still the stuff of sci-fi movies, but there are regular breakthroughs in the field of medical science that suggest that such a future might one day be possible – one example is a new nanoshell treatment from a team working at the University of Michigan in the US and reported in Gizmag.

Instead of using foreign cells or molecules to patch up and regrow damaged bone tissue, the new technique uses polymer nanoshells – microscopic capsules inside the body – to deliver microRNA molecules right to the site of an injury. Once the shells begin to break down, the microRNA molecules are released and instruct the surrounding cells to ‘switch on’ their natural bone-building and healing mechanisms. It’s a bit like a site manager arriving on the scene of a broken-down development and telling his construction workers to get busy with the rebuilding process.

There are a couple of key advantages to this new technique. One, the shell is designed to degrade slowly, leading to a gradual release of the microRNA molecules and thus ongoing restorative treatment that can last for a month or more. Second, the process uses the body’s own cells rather than introducing foreign healing agents – an approach that can sometimes cause cell rejection or even tumours associated with the injury.

Read more

Imagine: What happens when you’re in 2027 on the job competing with other AI; and there is so much information exposed to you that you’re unable to scan & capture all of it onto your various devices and personal robot. And, the non-intrusive nanobot for brain enhancement is still years away. Do you finally take a few hundred dollars & get the latest chip implant requiring a tricky surgery for your brain or wait for the nanobot? These are questions that folks will have to assess for themselves; and this could actually streamline/ condition society into a singularity culture. https://lnkd.in/bTVAjhb

A mom pushes a stroller down the sidewalk while Skyping. A family of four sits at the dinner table plugged into their cell phones with the TV blaring in the background. You get through two pages in a book before picking up your laptop and scrolling through a bottomless stream of new content.

Information technology has created a hyper-connected, over-stimulated, distracted and alienated world. We’ve been living long enough with internet-connected computers and other mobile devices to have begun to take it for granted.

Continue reading “Why Digital Overload Is Now Central to the Human Condition” »

Allows for more easily building tiny machines, biomedical sensors, optical computers, solar panels, and other devices — no complex clean room required; portable version planned.

Illustration of the bubble-pen pattern-writing process using an optically controlled microbubble on a plasmonic substrate. The small blue spheres are colloidal nanoparticles. (credit: Linhan Lin et al./Nano Letters)

Continue reading “‘Bubble pen’ can precisely write patterns with nanoparticles as small as 1 nanometer” »

Excellent news; Intellia to continue their focus of leveraging the CRISPR/Cas9 across a variety of immune cells, such as natural killer cells and T-cells. From my own experiences with T-cells and other blood disorders; this is a big deal and one that I personally excited to see what potential cures and improvements come about.

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Intellia Therapeutics, a leading gene-editing company, has launched a new division, eXtellia Therapeutics, with the intent of focusing resources and research on ex vivo applications of the novel technology, CRISPR/Cas9. As in vivo and ex vivo programs require different competencies in research, manufacturing and commercialization, eXtellia Therapeutics is being launched to accelerate Intellia’s efforts in areas of significant unmet medical need – immuno-oncology, autoimmune and inflammatory diseases – using an ex vivo approach. Intellia will continue its in vivo programs and strategy through a dedicated scientific team.

“We are excited to announce the establishment of eXtellia, increasing our footprint in ex vivo gene editing for oncology and autoimmune diseases,” said Nessan Bermingham, Ph.D., Chief Executive Officer and Founder, Intellia Therapeutics. “eXtellia enables us to bring together the required capabilities needed to take the CRISPR/Cas9 technology beyond Intellia’s emerging in vivo, HSC and CAR-T efforts. We believe eXtellia further positions us to maximize the CRISPR/ Cas9 opportunity to address severe unmet medical needs for patients.”

Read more

This is excellent news for Epilepsy.

Epilepsy, a disorder in which nerve cell activity in the brain is disturbed, causing seizures, is the fourth most common neurological problem, following only migraine, stroke and Alzheimer’s. There is no cure for epilepsy, but there are a variety of treatment options. The disease is estimated to affect 2.2 million people in the U.S., with 150,000 people developing the condition each year.

Personalized medicine Scientists at AES discussed how new technologies, such as gene editing using CRISPR-Cas9, and next-generation sequencing, are empowering them to take a new crack at the human genome and find new ways to diagnose and treat epilepsy.

Continue reading “Genomics, Cannabidiols Drive Epilepsy Research” »

Tardigrades, or “water bears,” are renowned for their remarkable survival skills. But these microscopic creatures are far more indestructible than we thought. In a recent experiment, scientists in Japan successfully revived a tardigrade that had been frozen for more than three decades.

That’s a new record.

Tardigrades are tiny water-dwelling extremophiles that are capable of withstanding some of the most severe environmental conditions, including freezing, total dehydration, radiation, and even the vacuum of space. Much of this has to do with their extraordinary genome, of which nearly 18% is comprised of DNA from other organisms, including plants, fungi, bacteria, and viruses.

Read more